26 November 2020Muireann Bolger

Five minutes with… Jacqueline Mulryne

Amid the unprecedented challenges presented by COVID-19, questions around the use of second medical use (SMU) patents have become increasingly pertinent. On Tuesday December 1, LSPN Connect ’s session: Addressing Second Medical Use Infringement: An Evaluation of Recent SMU Cases will examine a number of key issues relating to this pivotal area of life sciences IP.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

MedTech

Invisalign maker secures first China win against clear aligner rival

13 August 2026 Clear aligner rivals are fighting over orthodontic technology across several major markets and the latest development in China has raised the stakes.

Careers

Holland & Hart adds high-stakes patent litigation team from Ashurst Perkins Coie

13 August 2026 Less than a month after the merger between Ashurst and Perkins Coie, the new team brings expertise in high-stakes patent matters—including medtech and biotech—in the US.

Regulation & Industry

Exclusive: ‘In the end, I did it my own way’ and became a UPC judge

12 August 2026 Unified Patent Court judge Margot Kokke has had an unconventional and oft-interrupted career as the “trailing spouse” of a diplomat. She talks to Sarah Speight about this and more in the fourth in a series of interviews with women judges at the court.

More features

Invisalign maker secures first China win against clear aligner rival

Holland & Hart adds high-stakes patent litigation team from Ashurst Perkins Coie

Exclusive: ‘In the end, I did it my own way’ and became a UPC judge

Lilly mounts defence as generics circle Mounjaro and Zepbound

Reading Stief, Haedicke and Wünsche, with the memory of a decade fought in Germany

Kirkland clears conflicts hurdle in trade secrets spat

Former senior attorney-advisor to ITC commissioners joins Mintz

Novo’s Dutch win sends ‘clear message’ to unapproved semaglutide sellers

Five minutes with… Jacqueline Mulryne

More on this story

Editor's picks

Editor's picks

More features